Matches in Nanopublications for { ?s ?p "[The results indicate that MOR agonists may prevent acute hepatitis and hold promising therapeutic use to maintain remission in both chronic inflammatory bowel and liver diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP323385.RAS8t-z-eaXAR-ocGAna3scY4jrVd64oa2rrsUbG0T0PY130_assertion description "[The results indicate that MOR agonists may prevent acute hepatitis and hold promising therapeutic use to maintain remission in both chronic inflammatory bowel and liver diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323385.RAS8t-z-eaXAR-ocGAna3scY4jrVd64oa2rrsUbG0T0PY130_provenance.
- assertion description "[The results indicate that MOR agonists may prevent acute hepatitis and hold promising therapeutic use to maintain remission in both chronic inflammatory bowel and liver diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The results indicate that MOR agonists may prevent acute hepatitis and hold promising therapeutic use to maintain remission in both chronic inflammatory bowel and liver diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP593813.RAXgOKbwPrzRjXB6g27pp4XGF5J8MdTIdze4D5AWzwd1A130_assertion description "[The results indicate that MOR agonists may prevent acute hepatitis and hold promising therapeutic use to maintain remission in both chronic inflammatory bowel and liver diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593813.RAXgOKbwPrzRjXB6g27pp4XGF5J8MdTIdze4D5AWzwd1A130_provenance.
- NP593819.RAtDcniaGVJpdK8WjEYGGuRiE7m-VBO89rGFEi6eRGKYs130_assertion description "[The results indicate that MOR agonists may prevent acute hepatitis and hold promising therapeutic use to maintain remission in both chronic inflammatory bowel and liver diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593819.RAtDcniaGVJpdK8WjEYGGuRiE7m-VBO89rGFEi6eRGKYs130_provenance.
- NP603612.RAJkFo8J0rs99ioVW2snhTQTGVR3R7pSUsI1aVdrrjuD8130_assertion description "[The results indicate that MOR agonists may prevent acute hepatitis and hold promising therapeutic use to maintain remission in both chronic inflammatory bowel and liver diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603612.RAJkFo8J0rs99ioVW2snhTQTGVR3R7pSUsI1aVdrrjuD8130_provenance.
- NP603494.RA-aB3J-xjFNW10HE6HRQjqtDxbU_Km_t7XGobWv6r6SU130_assertion description "[The results indicate that MOR agonists may prevent acute hepatitis and hold promising therapeutic use to maintain remission in both chronic inflammatory bowel and liver diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603494.RA-aB3J-xjFNW10HE6HRQjqtDxbU_Km_t7XGobWv6r6SU130_provenance.